Kura Oncology, Inc. (KURA)

CIK 1422143 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kura Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Oct 27, 2026SCHEDULE 13G/A0002012383-26-003813
Sep 29, 202640001193125-26-407939
Sep 29, 202640001193125-26-407936
Sep 29, 202640001193125-26-407937
Sep 29, 20261440001950047-26-009865
Sep 29, 202640001193125-26-407938
Sep 29, 20261440001950047-26-009866
Sep 29, 202640001193125-26-407935
Sep 29, 20261440001950047-26-009864
Sep 28, 20261440001193125-26-405713
Sep 28, 20261440001193125-26-405710
Sep 28, 20261440001950047-26-009845
Sep 28, 20261440001193125-26-405711
Sep 28, 20261440001193125-26-405751
Sep 28, 20261440001193125-26-405712
Sep 25, 202640001193125-26-402815
Sep 24, 20261440001950047-26-009786
Sep 10, 202640001193125-26-387934
Sep 10, 202630001193125-26-387926
Sep 9, 20268-K0001193125-26-385881
Sep 8, 20268-K0001193125-26-384363
Aug 24, 202640001193125-26-363812
Aug 24, 202640001193125-26-363810
Aug 21, 202640001193125-26-361184
Aug 21, 20261440001950047-26-008548